Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Dosimetric evaluation of MRI-based treatment planning for prostate cancerThe materials in this paper have been presented in part at the San Diego 2003 AAPM.

Dosimetric evaluation of MRI-based treatment planning for prostate cancerThe materials in this... The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dosevolume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5%. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Physics in Medicine and Biology IOP Publishing

Dosimetric evaluation of MRI-based treatment planning for prostate cancerThe materials in this paper have been presented in part at the San Diego 2003 AAPM.

Download PDF
14 pages

Loading next page...
 
/lp/iop-publishing/dosimetric-evaluation-of-mri-based-treatment-planning-for-prostate-4ONF0NQltK

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright 2004 IOP Publishing Ltd
ISSN
0031-9155
eISSN
1361-6560
DOI
10.1088/0031-9155/49/22/010
Publisher site
See Article on Publisher Site

Abstract

The purpose of this study is to evaluate the dosimetric accuracy of MRI-based treatment planning for prostate cancer using a commercial radiotherapy treatment planning system. Three-dimensional conformal plans for 15 prostate patients were generated using the AcQPlan system. For each patient, dose distributions were calculated using patient CT data with and without heterogeneity correction, and using patient MRI data without heterogeneity correction. MR images were post-processed using the gradient distortion correction (GDC) software. The distortion corrected MR images were fused to the corresponding CT for each patient for target and structure delineation. The femoral heads were delineated based on CT. Other anatomic structures relevant to the treatment (i.e., prostate, seminal vesicles, lymph notes, rectum and bladder) were delineated based on MRI. The external contours were drawn separately on CT and MRI. The same internal contours were used in the dose calculation using CT- and MRI-based geometries by directly transferring them between MRI and CT as needed. Treatment plans were evaluated based on maximum dose, isodose distributions and dosevolume histograms. The results confirm previous investigations that there is no clinically significant dose difference between CT-based prostate plans with and without heterogeneity correction. The difference in the target dose between CT- and MRI-based plans using homogeneous geometry was within 2.5%. Our results suggest that MRI-based treatment planning is suitable for radiotherapy of prostate cancer.

Journal

Physics in Medicine and Biology – IOP Publishing

Published: Nov 21, 2004

There are no references for this article.